124 related articles for article (PubMed ID: 1671413)
1. Synthesis and biological evaluation of cyclopropyl analogues of 2-amino-5-phosphonopentanoic acid.
Dappen MS; Pellicciari R; Natalini B; Monahan JB; Chiorri C; Cordi AA
J Med Chem; 1991 Jan; 34(1):161-8. PubMed ID: 1671413
[TBL] [Abstract][Full Text] [Related]
2. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
Foster AC; Wong EH
Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
[TBL] [Abstract][Full Text] [Related]
3. Effects of ifenprodil on the N-methyl-D-aspartate receptor ionophore complex in rat brain.
Ogita K; Ohkawara A; Suzuki T; Ohgaki T; Uchida S; Meguri H; Yoneda Y
Neurochem Int; 1992 Jul; 21(1):135-47. PubMed ID: 1363860
[TBL] [Abstract][Full Text] [Related]
4. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
[TBL] [Abstract][Full Text] [Related]
5. Polyamine effects upon N-methyl-D-aspartate receptor functioning: differential alteration by glutamate and glycine site antagonists.
Nussenzveig IZ; Sircar R; Wong ML; Frusciante MJ; Javitt DC; Zukin SR
Brain Res; 1991 Oct; 561(2):285-91. PubMed ID: 1686987
[TBL] [Abstract][Full Text] [Related]
6. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
[TBL] [Abstract][Full Text] [Related]
7. Further evidence for multiple forms of an N-methyl-D-aspartate recognition domain in rat brain using membrane binding techniques.
Zuo P; Ogita K; Suzuki T; Han D; Yoneda Y
J Neurochem; 1993 Nov; 61(5):1865-73. PubMed ID: 7901335
[TBL] [Abstract][Full Text] [Related]
8. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
Benveniste M; Mayer ML
Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
[TBL] [Abstract][Full Text] [Related]
11. Comparison of L-[3H]glutamate, D-[3H]aspartate, DL-[3H]AP5 and [3H]NMDA as ligands for NMDA receptors in crude postsynaptic densities from rat brain.
Foster AC; Fagg GE
Eur J Pharmacol; 1987 Jan; 133(3):291-300. PubMed ID: 2881792
[TBL] [Abstract][Full Text] [Related]
12. Competitive inhibition of NMDA-mediated responses by guanine nucleotides in brain synaptic membranes treated with Triton X-100.
Yoneda Y; Ogita K; Suzuki T; Enomoto R; Ping ZP
Neurosci Res; 1990 Nov; 9(2):114-25. PubMed ID: 1980527
[TBL] [Abstract][Full Text] [Related]
13. Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
Krogsgaard-Larsen P; Ferkany JW; Nielsen EO; Madsen U; Ebert B; Johansen JS; Diemer NH; Bruhn T; Beattie DT; Curtis DR
J Med Chem; 1991 Jan; 34(1):123-30. PubMed ID: 1825114
[TBL] [Abstract][Full Text] [Related]
14. [3H]CGP 39653 binding to the agonist site of the N-methyl-D-aspartate receptor is modulated by Mg2+ and polyamines independently of the arcaine-sensitive polyamine site.
Reynolds IJ
J Neurochem; 1994 Jan; 62(1):54-62. PubMed ID: 7903355
[TBL] [Abstract][Full Text] [Related]
15. L-homocysteate stimulates [3H]MK-801 binding to the phencyclidine recognition site and is thus an agonist for the N-methyl-D-aspartate-operated cation channel.
Schwarz S; Zhou GZ; Katki AG; Rodbard D
Neuroscience; 1990; 37(1):193-200. PubMed ID: 1700841
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques.
Yoneda Y; Ogita K
J Pharmacol Exp Ther; 1991 Oct; 259(1):86-96. PubMed ID: 1681092
[TBL] [Abstract][Full Text] [Related]
17. L-glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranes.
Olverman HJ; Jones AW; Watkins JC
Nature; 1984 Feb 2-8; 307(5950):460-2. PubMed ID: 6141527
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the N-methyl-D-aspartate (NMDA) receptor in the embryonic chick brain.
Jacobsson SO; Hedin H; Sellström A; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):625-33. PubMed ID: 9686938
[TBL] [Abstract][Full Text] [Related]
19. N-methyl-D-aspartate receptor binding is altered and seizure potential reduced in pregnant rats.
Standley CA
Brain Res; 1999 Oct; 844(1-2):10-9. PubMed ID: 10536256
[TBL] [Abstract][Full Text] [Related]
20. [3H]CGP 39653: a new N-methyl-D-aspartate antagonist radioligand with low nanomolar affinity in rat brain.
Sills MA; Fagg G; Pozza M; Angst C; Brundish DE; Hurt SD; Wilusz EJ; Williams M
Eur J Pharmacol; 1991 Jan; 192(1):19-24. PubMed ID: 1674916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
